How to Properly Test and Validate Pharmaceutical Raw Materials Before Production: A Step-by-Step Practical Guide

Photo: Trnava University / Unsplash

Pharmaceutical raw materials form the foundation of every medicinal product. Their quality, purity, and stability directly impact the efficacy, safety, and shelf life of the final product. Before entering the production process, it is therefore essential to conduct thorough inspection and validation of each batch of raw materials. This process includes not only laboratory tests but also documentation, traceability, and compliance with strict regulatory requirements. In the following guide, we present a practical procedure for effectively testing and validating pharmaceutical raw materials to minimize risks of contamination, non-compliance with standards, or production failures.

1. Receipt and Documentation of Raw Materials: The First Step in Quality Control

Before any testing, it is essential to properly document the receipt of each batch of pharmaceutical raw materials. This includes verifying the delivery note, the supplier's Certificate of Analysis (CoA), and comparing them with the order. Check that all mandatory information is provided in accordance with REACH and CLP regulations, including substance identification, batch number, expiry date, and any safety symbols. It is also important to verify that the supplier meets the GMP (Good Manufacturing Practice) certification requirements for pharmaceutical raw materials.

Each batch should be immediately labeled with a unique identification number and placed in quarantine until it passes all tests. At this stage, it is also recommended to perform a visual inspection of the packaging – checking for damage, contamination, or incorrect labeling. Any discrepancies should be immediately addressed with the supplier, and the batch should be temporarily blocked from further processing.

2. Physicochemical Testing: Key Parameters for Purity Verification

Following the documentation check, physicochemical testing is performed to verify the key properties of the raw material. Standard parameters include determining moisture content (e.g., using the Karl Fischer method for organic substances), density, pH of the solution, melting or boiling point, and solubility in defined solvents. These tests are conducted in accordance with applicable standards and standard test methods that are part of the manufacturer's internal specifications.

For pharmaceutical raw materials, the determination of the active substance content (e.g., by titration, spectrophotometry, or chromatography) and the presence of impurities are also critical. Limit values for impurities are often defined in pharmacopoeial monographs (e.g., the European Pharmacopoeia), and exceeding them may lead to batch rejection. Additionally, some substances are tested for stability at specified temperatures and humidity levels to prevent degradation during storage.

Photo: Julia Koblitz / Unsplash

3. Microbiological control: Preventing contamination in the production process

Microbiological purity is absolutely critical for pharmaceutical raw materials, especially for substances intended for parenteral or ophthalmic preparations. Standard tests include the determination of the total aerobic microbial count (TAMC), yeasts and moulds (TYMC), and specific pathogens such as *Escherichia coli*, *Salmonella*, or *Pseudomonas aeruginosa*. These tests are performed using cultivation methods on selective media in accordance with current pharmaceutical standards.

For raw materials that cannot be sterilised in the final production step (e.g. thermolabile substances), it is necessary to validate the supplier and regularly verify the microbiological quality of their manufacturing process. In some cases, an endotoxin test (e.g. LAL test) is also performed for raw materials intended for injectable applications. If contamination is detected, the batch is immediately rejected and an investigation into the causes is conducted.

4. Validation and Release of Raw Materials: The Final Decision on Use

After completing all tests, the results are evaluated and compared with internal specifications and pharmacopoeial requirements. If all parameters meet the established limits, the batch is released for production and labelled "Released". Otherwise, an additional investigation is conducted, or the batch is rejected and returned to the supplier. It is important to maintain detailed documentation of all tests and decisions for potential audits or complaints.

Raw material validation also includes an assessment of risks associated with its use, including potential interactions with other ingredients or the impact on the stability of the final product. For new suppliers or raw materials, extended testing is recommended, including pilot production batches, to verify compatibility with the manufacturing process. Only after successfully completing all these steps can the raw material be considered fully validated and safe for pharmaceutical production.

Photo: CDC / Unsplash

Stability and Storage Conditions: Key Factors for Preserving Raw Material Quality

Stability of pharmaceutical raw materials is crucial for maintaining their efficacy and safety throughout the storage period. Before release into production, it is necessary to verify that the raw materials meet stability requirements according to supplier specifications and applicable regulations, such as REACH. Stability testing involves monitoring the effects of temperature, humidity, and light on the chemical and physical integrity of the substance. Standard test methods are used to determine whether degradation, color change, odor, or impurity formation occurs.

Storage conditions must be carefully defined and adhered to. For example, some surfactants or polyols require storage at a temperature of 15–25 °C and low humidity to prevent hydrolysis or microbial contamination. For sensitive raw materials, such as certain coating additives, the use of an inert atmosphere or protective packaging may be necessary. Documentation of storage conditions and regular stability checks are essential to demonstrate compliance with quality requirements and regulatory standards.

Compatibility of raw materials with production equipment and other components

Before incorporating a raw material into the production process, it is necessary to verify its compatibility with the materials of the production equipment and other components of the final product. Some chemicals, such as strong acids or bases, may corrode metal parts of the equipment or react with seals and hoses, leading to leaks or contamination. Compatibility testing involves laboratory tests that simulate production process conditions, including temperature, pressure, and exposure time.

Compatibility of the raw material with other components, such as fillers, stabilizers, or preservatives, is also crucial. For example, some surfactants may interact with certain types of polyols, leading to the formation of undesirable by-products or changes in viscosity. To verify compatibility, accelerated stability tests are conducted, during which raw material mixtures are exposed to extreme conditions to identify potential issues. The results of these tests help prevent production errors and ensure consistent quality of the final product.

Documentation and Traceability: How to Ensure Full Process Transparency

Documentation is a fundamental pillar of pharmaceutical raw material validation and must be maintained with the utmost care. Every step of testing, from raw material receipt to its release into production, must be thoroughly recorded and archived. This includes protocols for physico-chemical and microbiological tests, stability test results, records of storage conditions, and any deviations from specifications. Traceability is key for the rapid identification and resolution of issues, such as in the case of complaints or audits.

To ensure full transparency, the use of electronic documentation management systems is recommended, as they enable easy searching and sharing of information between departments. Each batch of raw material should have a unique identification code assigned, which is included in all related documents. It is also important to regularly update internal regulations and procedures in accordance with the latest regulatory requirements, such as the CLP/GHS regulation for the classification and labelling of chemicals.

Need help selecting or testing raw materials?

Every pharmaceutical raw material requires an individual approach and precise documentation. GCG Group provides detailed technical data sheets and safety data sheets (SDS) for all supplied raw materials in compliance with REACH and CLP. Our experts will be happy to advise you on selecting suitable testing and validation methods according to the specific requirements of your production. Contact us – or browse our catalogue of over 1,300 products.